Ratings Rubicon Organics Inc. Canadian Securities Exchange

Equities

End-of-day quote Canadian Securities Exchange Other stock markets 23:00:00 15/02/2021 GMT			5-day change	1st Jan Change
4.1 ^CAD	+7.89%		+15.82%	+13.26%

05-16	Transcript : Rubicon Organics Inc., Q1 2024 Earnings Call, May 16, 2024
05-16	Rubicon Organics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.

Analysts covering this company mostly recommend stock overweighting or purchase.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
The company has insufficient levels of profitability.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
For the past year, analysts have significantly revised downwards their profit estimates.
For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
The group usually releases earnings worse than estimated.

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
RUBICON ORGANICS INC.	+13.26%	20M		-
AYR WELLNESS INC.	+4.94%	212M		-
ASCEND WELLNESS HOLDINGS, INC.	-15.46%	175M		-
ORGANIGRAM HOLDINGS INC.	+26.16%	165M		C
IANTHUS CAPITAL HOLDINGS, INC.	-28.57%	121M	-	-
BAKHU HOLDINGS, CORP.	+300.00%	121M	-	-
JUSHI HOLDINGS INC.	+21.20%	110M		-
INTERCURE LTD.	+90.39%	105M	-	-
4FRONT VENTURES CORP.	-15.38%	73.86M	-	-

Investor Rating

Trading Rating

ESG Refinitiv

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality